Literature DB >> 16947086

The biological functions of the versatile transcription factors STAT3 and STAT5 and new strategies for their targeted inhibition.

Sylvane Desrivières1, Christian Kunz, Itamar Barash, Vida Vafaizadeh, Corina Borghouts, Bernd Groner.   

Abstract

Signal transducers and activators of transcription (STATs) comprise a unique family of transcription factors, which transmit the interactions of cytokines, hormones and growth factors with their cell surface receptors into transcriptional programs. The mechanism of STAT activation has been well-established and comprises tyrosine phosphorylation, dimerization, nuclear translocation, binding to specific DNA response elements, recruitment of co-activators or co-repressors and transcriptional induction or repression of target genes. Gene deletion, microarrays, proteomics and chromatin immunoprecipitation experiments have revealed target genes with a broad range of functions regulated by STAT3 and STAT5. In the mammary gland, STAT5-induced genes contribute mainly to the prolactin dependent lobulo-alveolar development, whereas STAT3 induced genes control apoptosis during involution. Crucial effects have also been observed in other tissues. The germ line deletion of STAT3 or STAT5 causes early embryonal or perinatal lethality in mice. STAT5 is also required for proliferation of T- and B-cells and hematopoietic stem cell self-renewal. Deregulated STAT activity is often found associated with tumorigenesis and activated STATs seem to be limiting components in tumor cells. This review summarizes the functions of STAT3 and STAT5 in different cell types and the strategies that are used to counteract their action in tumor cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16947086     DOI: 10.1007/s10911-006-9014-4

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  105 in total

1.  Control of stem cell self-renewal in Drosophila spermatogenesis by JAK-STAT signaling.

Authors:  N Tulina; E Matunis
Journal:  Science       Date:  2001-12-21       Impact factor: 47.728

2.  Stem cell self-renewal specified by JAK-STAT activation in response to a support cell cue.

Authors:  A A Kiger; D L Jones; C Schulz; M B Rogers; M T Fuller
Journal:  Science       Date:  2001-12-21       Impact factor: 47.728

3.  The genes induced by signal transducer and activators of transcription (STAT)3 and STAT5 in mammary epithelial cells define the roles of these STATs in mammary development.

Authors:  Richard W E Clarkson; Marion P Boland; Ekaterini A Kritikou; Jennifer M Lee; Tom C Freeman; Paul G Tiffen; Christine J Watson
Journal:  Mol Endocrinol       Date:  2005-11-17

4.  In vivo antitumor efficacy of STAT3 blockade using a transcription factor decoy approach: implications for cancer therapy.

Authors:  Sichuan Xi; William E Gooding; Jennifer Rubin Grandis
Journal:  Oncogene       Date:  2005-02-03       Impact factor: 9.867

5.  Stat5a is mandatory for adult mammary gland development and lactogenesis.

Authors:  X Liu; G W Robinson; K U Wagner; L Garrett; A Wynshaw-Boris; L Hennighausen
Journal:  Genes Dev       Date:  1997-01-15       Impact factor: 11.361

6.  Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice.

Authors:  Michelle A Blaskovich; Jiazhi Sun; Alan Cantor; James Turkson; Richard Jove; Saïd M Sebti
Journal:  Cancer Res       Date:  2003-03-15       Impact factor: 12.701

7.  Farnesyl transferase inhibitor R115777 induces apoptosis of human myeloma cells.

Authors:  S Le Gouill; C Pellat-Deceunynck; J-L Harousseau; M-J Rapp; N Robillard; R Bataille; M Amiot
Journal:  Leukemia       Date:  2002-09       Impact factor: 11.528

Review 8.  Turning off signal transducer and activator of transcription (STAT): the negative regulation of STAT signaling.

Authors:  Weiguo Chen; Michael O Daines; Gurjit K Khurana Hershey
Journal:  J Allergy Clin Immunol       Date:  2004-09       Impact factor: 10.793

Review 9.  The role of signal transducer and activator of transcription factors in leukemogenesis.

Authors:  David W Sternberg; D Gary Gilliland
Journal:  J Clin Oncol       Date:  2004-01-15       Impact factor: 44.544

10.  Epidermal growth factor receptor-mediated activation of Stat3 during multistage skin carcinogenesis.

Authors:  Keith Syson Chan; Steve Carbajal; Kaoru Kiguchi; John Clifford; Shigetoshi Sano; John DiGiovanni
Journal:  Cancer Res       Date:  2004-04-01       Impact factor: 12.701

View more
  26 in total

Review 1.  Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment.

Authors:  Ana C Garrido-Castro; Nancy U Lin; Kornelia Polyak
Journal:  Cancer Discov       Date:  2019-01-24       Impact factor: 39.397

2.  An integrated genomic analysis of aryl hydrocarbon receptor-mediated inhibition of B-cell differentiation.

Authors:  K Nadira De Abrew; Norbert E Kaminski; Russell S Thomas
Journal:  Toxicol Sci       Date:  2010-09-06       Impact factor: 4.849

3.  STAT subtype specificity and ischemic preconditioning in mice: is STAT-3 enough?

Authors:  Michael D Goodman; Sheryl E Koch; Muhammad R Afzal; Karyn L Butler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-12-03       Impact factor: 4.733

4.  Singleminded-2s (Sim2s) promotes delayed involution of the mouse mammary gland through suppression of Stat3 and NFκB.

Authors:  Kelly C Scribner; Elizabeth A Wellberg; Richard P Metz; Weston W Porter
Journal:  Mol Endocrinol       Date:  2011-02-03

5.  STAT3 genetic variant, alone and in combination with STAT5b polymorphism, contributes to breast cancer risk and clinical outcomes.

Authors:  Haishan Zhao; Zhe Wang; Huizhe Wu; Qinghuan Xiao; Weifan Yao; Enhua Wang; Yong Liu; Minjie Wei
Journal:  Med Oncol       Date:  2014-12-07       Impact factor: 3.064

6.  S731 in the transactivation domain modulates STAT5b activity.

Authors:  Amanda M Weaver; Corinne M Silva
Journal:  Biochem Biophys Res Commun       Date:  2007-08-28       Impact factor: 3.575

7.  Distinct gene-expression profiles characterize mammary tumors developed in transgenic mice expressing constitutively active and C-terminally truncated variants of STAT5.

Authors:  Tali Eilon; Itamar Barash
Journal:  BMC Genomics       Date:  2009-05-18       Impact factor: 3.969

8.  Progesterone receptor A-regulated gene expression in mammary organoid cultures.

Authors:  Sarah J Santos; Mark D Aupperlee; Jianwei Xie; Srinivasan Durairaj; Richard Miksicek; Susan E Conrad; Jeffrey R Leipprandt; Ying S Tan; Richard C Schwartz; Sandra Z Haslam
Journal:  J Steroid Biochem Mol Biol       Date:  2009-04-19       Impact factor: 4.292

9.  Computational identification of transcription frameworks of early committed spermatogenic cells.

Authors:  Claudia Lalancette; Adrian E Platts; Yi Lu; Shiyong Lu; Stephen A Krawetz
Journal:  Mol Genet Genomics       Date:  2008-07-10       Impact factor: 3.291

10.  A dual role for oncostatin M signaling in the differentiation and death of mammary epithelial cells in vivo.

Authors:  Paul G Tiffen; Nader Omidvar; Nuria Marquez-Almuina; Dawn Croston; Christine J Watson; Richard W E Clarkson
Journal:  Mol Endocrinol       Date:  2008-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.